Webinar | Women’s Nutrition: Nourishing Womanhood From Pregnancy To Menopause
11 September | 12 PM ET: Register Now

shotsy

Shotsy is a tracking application tailored for users of GLP-1 medications such as Ozempic, Mounjaro, Wegovy, and Zepbound.
  • Consumer Healthcare
  • Drug Delivery and Devices
  • Wearables

Innovation

Industry Problem

GLP-1 users need a reliable way to track injections, side effects, weight, nutrition, and treatment progress.

R&D Focus

GLP-1 medication tracking and analytics

Innovative Solution

Shotsy is a tracking application tailored for users of GLP-1 medications such as Ozempic, Mounjaro, Wegovy, and Zepbound. It enables them to log their weekly injections, monitor side effects, and track weight loss, protein consumption, and other health metrics235.

Investment Funding

Last Funding Stage

Pre-Seed

Total Funding Amount

2.3M

Last Funding Amount

2.3M

Last Funding Date

13-02-2025

Startup Stage

Seed

Lead Investors

Esther Dyson, Springbank Collective, Coalition Operators, Adverb Ventures

About

Shotsy is a tracking application tailored for users of GLP-1 medications such as Ozempic, Mounjaro, Wegovy, and Zepbound. It enables them to log their weekly injections, monitor side effects, and track weight loss, protein consumption, and other health metrics235. The app offers detailed analytics and charts for visualizing progress

Products

Product

Shotsy app – logs GLP-1 injections, side effects, weight, protein intake and progress analytics.

Demo Product or Complete Product?

Complete mobile application – available to GLP-1 medication users.

Something missing or incorrect on this page? Help us enrich this information